Springvest Oyj

SPRING

FI4000369442

Investment Management & Fund Operators

Market Closed - Nasdaq Helsinki Other stock markets 09:43:02 2024-05-10 EDT			5-day change	1st Jan Change
4.92 ^EUR	0.00%		+2.50%	+16.59%

04-26	Agronomics investee raises additional EUR8 million	AN
04-26	Agronomics' Portfolio Company Raises Additional EUR8 Million for New Protein Product	MT

LS CancerDiag Ltd announced that it has received €5.4 million in funding from Springvest Oyj

March 01, 2023

LS CancerDiag Ltd announced that it has raised €5.4 million in a round of funding on March 2, 2023. The transaction included participation from new investor Springvest Oyj.

Latest news about Springvest Oyj

Agronomics investee raises additional EUR8 million	04-26	AN
Agronomics' Portfolio Company Raises Additional EUR8 Million for New Protein Product	04-26	MT
Solar Foods Ltd. announced that it has received ?16 million in funding from Springvest Oyj, VTT Ventures Ltd, Lifeline Ventures Oy, Oy Fazer Services AB, Happiness Capital	04-25	CI
Desentum Oy announced that it has received ?12 million in funding from Springvest Oyj	01-30	CI
Instem acquisition by Ichor sanctioned by UK court	11-16	AN
Kuva Space announced that it has received ?16.6 million in funding from Voima Ventures, Nordic FoodTech VC Oy, Business Finland Venture Capital Ltd, Springvest Oyj, Earth Venture Capital	11-01	CI
Solar Foods Ltd. announced that it has received ?8 million in funding from Springvest Oyj	23-10-24	CI
Sulapac Oy announced that it has received â‚¬6 million in funding from Springvest Oyj	23-05-30	CI
LS CancerDiag Ltd announced that it has received €5.4 million in funding from Springvest Oyj	23-03-01	CI
Finland's Desentum Obtains $9 Million Funding for Allergy Vaccine Candidate	22-01-21	MT
Desentum Oy announced that it has received €8 million in funding from Springvest Oyj	22-01-20	CI

Springvest Oyj is a Finland-based investment company. Springvest is a partner of growth companies and target company investors, offering growth financing and the opportunity to invest in unlisted shares. Springvest Oyj is a minority owner of its portfolio companies. The portfolio includes shares in more than 30 companies, including Northern Antibiotics Oy, which develops derivatives for the treatment of infections caused by highly resistant Gram-negative bacteria, Paptic Oy, which responds to the global plastic waste problem by introducing wood-based alternatives to plastic films, Claned Group Oy Ab, which offers the learner suitable learning material and a digital learning environment, as well as Earth House Oy, which develops and produces small houses for the needs of mass construction in developing countries.

Sector

Investment Management & Fund Operators

More about the company

Income Statement Evolution

More financial data

Ratings for Springvest Oyj

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

4.92 EUR

Average target price

5.5 EUR

Spread / Average Target

+11.79%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Private Equity

	1st Jan change	Capi.
SPRINGVEST OYJ	+16.59%	29.52M
PARTNERS GROUP HOLDING AG	+3.75%	36.06B
CVC CAPITAL PARTNERS PLC	0.00%	18.31B
ONEX CORPORATION	+3.03%	5.36B
CORPORACIÓN FINANCIERA ALBA, S.A.	+0.62%	3.14B
GOLUB CAPITAL BDC, INC.	+10.79%	2.87B
PETERSHILL PARTNERS PLC	+18.81%	2.82B
BRIDGEPOINT GROUP PLC	-17.26%	2.29B
INVESTCORP CAPITAL PLC	+4.02%	1.24B
RATOS AB	+5.32%	1.16B

Private Equity

Springvest Oyj

Equities

SPRING

FI4000369442

Investment Management & Fund Operators

LS CancerDiag Ltd announced that it has received €5.4 million in funding from Springvest Oyj

Latest news about Springvest Oyj

Chart Springvest Oyj

Company Profile

Income Statement Evolution

Ratings for Springvest Oyj

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Private Equity